Nichd: r & d: best pharmaceuticals for children act (bpca) pediatric trials network (PTN): non-severable
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N94025D00003
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Task orders
- 4 $23,788,195 obligated
Award facts
- Opportunity
-
- Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN) Pre-Solicitation · 75N94024R00008 · Posted Jan 3, 2024
- Combined order value
-
- $23,788,195 Current, with exercised options
- $45,987,587 Potential, with all options
- Last date to order 17% complete
- IDV ceiling 16% used
- $149,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Child Health and Human Development awarded a single-award indefinite-delivery contract to Duke University with a ceiling value of $149 million on June 4, 2025, for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN), a research and development effort extending through June 3, 2033.
The contract carries no set-aside designation. Work is performed in Durham, North Carolina. The IDIQ supports design, conduct, and oversight of clinical, scientific, and technical aspects of pediatric drug development, including pre-clinical studies, formulations development, and Phase 1–3 pediatric clinical trials under the BPCA framework. NAICS code 541715 and PSC code R425 apply.
Two delivery orders have been issued under this IDIQ to date. The first, valued at $17.2 million and awarded June 4, 2025, funds core function activities through June 3, 2032, including establishment and maintenance of centralized expert teams to develop protocols and informed consent forms. The second, valued at $14.8 million and awarded September 20, 2025, supports clinical trials infrastructure to develop protocols, conduct pre-clinical studies, and execute Phases 1–3 pediatric clinical trials, with completion targeted for September 19, 2030. Both orders are cost-no-fee arrangements performed in Durham, North Carolina.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| University Of Utah | $149,999 |
Quick answers
Who was awarded contract 75N94025D00003?
75N94025D00003 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on June 4, 2025.
How much is contract 75N94025D00003 worth?
Orders under 75N94025D00003 have obligated $23,788,195. Their combined potential value, with all options, is $45,987,587. 75N94025D00003's own ceiling is $149,000,000.
How many orders have been placed under contract 75N94025D00003?
4 orders have been placed under 75N94025D00003, the latest on September 28, 2026.
Who can order from contract 75N94025D00003?
75N94025D00003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N94025D00003 competed?
The extent of competition for 75N94025D00003 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV